194 related articles for article (PubMed ID: 7573259)
1. The angiotensin sensitivity test and low-dose aspirin are ineffective methods to predict and prevent hypertensive disorders in nulliparous pregnancy.
Kyle PM; Buckley D; Kissane J; de Swiet M; Redman CW
Am J Obstet Gynecol; 1995 Sep; 173(3 Pt 1):865-72. PubMed ID: 7573259
[TBL] [Abstract][Full Text] [Related]
2. Does low-dose aspirin initiated before 11 weeks' gestation reduce the rate of preeclampsia?
Chaemsaithong P; Cuenca-Gomez D; Plana MN; Gil MM; Poon LC
Am J Obstet Gynecol; 2020 May; 222(5):437-450. PubMed ID: 31494125
[TBL] [Abstract][Full Text] [Related]
3. Low-dose aspirin is associated with reduced spontaneous preterm birth in nulliparous women.
Andrikopoulou M; Purisch SE; Handal-Orefice R; Gyamfi-Bannerman C
Am J Obstet Gynecol; 2018 Oct; 219(4):399.e1-399.e6. PubMed ID: 29913174
[TBL] [Abstract][Full Text] [Related]
4. Chronotherapy with low-dose aspirin for prevention of complications in pregnancy.
Ayala DE; Ucieda R; Hermida RC
Chronobiol Int; 2013 Mar; 30(1-2):260-79. PubMed ID: 23004922
[TBL] [Abstract][Full Text] [Related]
5. Low-dose aspirin therapy to prevent preeclampsia.
Hauth JC; Goldenberg RL; Parker CR; Philips JB; Copper RL; DuBard MB; Cutter GR
Am J Obstet Gynecol; 1993 Apr; 168(4):1083-91; discussion 1091-3. PubMed ID: 8475955
[TBL] [Abstract][Full Text] [Related]
6. Aspirin and prevention of preeclampsia. Position statement of the use of low-dose aspirin in pregnancy by the Australasian Society for the Study of Hypertension in Pregnancy.
Brennecke SP; Brown MA; Crowther CA; Hague WM; King J; McCowan L; Morris J; North R; Pattison N; Tippett C
Aust N Z J Obstet Gynaecol; 1995 Feb; 35(1):38-41. PubMed ID: 7771997
[TBL] [Abstract][Full Text] [Related]
7. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin in prevention of preterm preeclampsia in subgroups of women according to their characteristics and medical and obstetrical history.
Poon LC; Wright D; Rolnik DL; Syngelaki A; Delgado JL; Tsokaki T; Leipold G; Akolekar R; Shearing S; De Stefani L; Jani JC; Plasencia W; Evangelinakis N; Gonzalez-Vanegas O; Persico N; Nicolaides KH
Am J Obstet Gynecol; 2017 Nov; 217(5):585.e1-585.e5. PubMed ID: 28784417
[TBL] [Abstract][Full Text] [Related]
8. Preeclampsia prevention: lessons from the low-dose aspirin therapy trials.
Heyborne KD
Am J Obstet Gynecol; 2000 Sep; 183(3):523-8. PubMed ID: 10992168
[TBL] [Abstract][Full Text] [Related]
9. Effect of low-dose aspirin on vascular refractoriness in angiotensin-sensitive primigravid women.
Wallenburg HC; Dekker GA; Makovitz JW; Rotmans N
Am J Obstet Gynecol; 1991 May; 164(5 Pt 1):1169-73. PubMed ID: 2035557
[TBL] [Abstract][Full Text] [Related]
10. Low-Dose Aspirin in Early Gestation for Prevention of Preeclampsia and Small-for-Gestational-Age Neonates: Meta-analysis of Large Randomized Trials.
Roberge S; Sibai B; McCaw-Binns A; Bujold E
Am J Perinatol; 2016 Jul; 33(8):781-5. PubMed ID: 26906184
[TBL] [Abstract][Full Text] [Related]
11. Risk factors for preeclampsia in healthy nulliparous women: a prospective multicenter study. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Sibai BM; Gordon T; Thom E; Caritis SN; Klebanoff M; McNellis D; Paul RH
Am J Obstet Gynecol; 1995 Feb; 172(2 Pt 1):642-8. PubMed ID: 7856699
[TBL] [Abstract][Full Text] [Related]
12. The impact of risk factors on aspirin's efficacy for the prevention of preterm birth.
Nuss EE; Hoffman MK; Goudar SS; Kavi A; Metgud M; Somannavar M; Okitawutshu J; Lokangaka A; Tshefu A; Bauserman M; Tembo AM; Chomba E; Carlo WA; Figueroa L; Krebs NF; Jessani S; Saleem S; Goldenberg RL; Kurhe K; Das P; Hibberd PL; Achieng E; Nyongesa P; Esamai F; Liechty EA; Bucher S; Goco N; Hemingway-Foday J; Moore J; McClure EM; Silver RM; Derman RJ;
Am J Obstet Gynecol MFM; 2023 Oct; 5(10):101095. PubMed ID: 37574046
[TBL] [Abstract][Full Text] [Related]
13. Study protocol for the randomised controlled trial: combined multimarker screening and randomised patient treatment with ASpirin for evidence-based PREeclampsia prevention (ASPRE).
O'Gorman N; Wright D; Rolnik DL; Nicolaides KH; Poon LC
BMJ Open; 2016 Jun; 6(6):e011801. PubMed ID: 27354081
[TBL] [Abstract][Full Text] [Related]
14. Usefulness of aspirin therapy in high-risk pregnant women with abnormal uterine artery Doppler ultrasound at 14-16 weeks pregnancy: randomized controlled clinical trial.
Ebrashy A; Ibrahim M; Marzook A; Yousef D
Croat Med J; 2005 Oct; 46(5):826-31. PubMed ID: 16158479
[TBL] [Abstract][Full Text] [Related]
15. Is low-dose aspirin therapy to prevent preeclampsia more efficacious in non-obese women or when initiated early in pregnancy?
Cantu JA; Jauk VR; Owen J; Biggio JR; Abramovici AR; Edwards RK; Tita AT
J Matern Fetal Neonatal Med; 2015 Jul; 28(10):1128-32. PubMed ID: 25048750
[TBL] [Abstract][Full Text] [Related]
16. Aspirin for Evidence-Based Preeclampsia Prevention trial: effect of aspirin on length of stay in the neonatal intensive care unit.
Wright D; Rolnik DL; Syngelaki A; de Paco Matallana C; Machuca M; de Alvarado M; Mastrodima S; Tan MY; Shearing S; Persico N; Jani JC; Plasencia W; Papaioannou G; Molina FS; Poon LC; Nicolaides KH
Am J Obstet Gynecol; 2018 Jun; 218(6):612.e1-612.e6. PubMed ID: 29505771
[TBL] [Abstract][Full Text] [Related]
17. Prevention of pregnancy-induced hypertension by calcium supplementation in angiotensin II-sensitive patients.
Sanchez-Ramos L; Briones DK; Kaunitz AM; Delvalle GO; Gaudier FL; Walker CD
Obstet Gynecol; 1994 Sep; 84(3):349-53. PubMed ID: 8058229
[TBL] [Abstract][Full Text] [Related]
18. Prevention of preeclampsia with low-dose aspirin in healthy, nulliparous pregnant women. The National Institute of Child Health and Human Development Network of Maternal-Fetal Medicine Units.
Sibai BM; Caritis SN; Thom E; Klebanoff M; McNellis D; Rocco L; Paul RH; Romero R; Witter F; Rosen M
N Engl J Med; 1993 Oct; 329(17):1213-8. PubMed ID: 8413387
[TBL] [Abstract][Full Text] [Related]
19. A multicenter, placebo-controlled pilot study of intravenous immune globulin treatment of antiphospholipid syndrome during pregnancy. The Pregnancy Loss Study Group.
Branch DW; Peaceman AM; Druzin M; Silver RK; El-Sayed Y; Silver RM; Esplin MS; Spinnato J; Harger J
Am J Obstet Gynecol; 2000 Jan; 182(1 Pt 1):122-7. PubMed ID: 10649166
[TBL] [Abstract][Full Text] [Related]
20. Effect of aspirin in pregnant women is dependent on increase in bleeding time.
Dumont A; Flahault A; Beaufils M; Verdy E; Uzan S
Am J Obstet Gynecol; 1999 Jan; 180(1 Pt 1):135-40. PubMed ID: 9914592
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
